Bristol-Myers Squibb Company (NYSE:BMY) | [$$] Bristol-Myers’ AstraZeneca Deal Is a Win

[at Barrons.com] – Hilliard Lyons Bristol-Myers Squibb agreed to sell its part of a diabetes-care collaboration to its partner, AstraZeneca. The two companies have collaborated on the development and commercialization of … Read . . . → Read More: Bristol-Myers Squibb Company (NYSE:BMY) | [$$] Bristol-Myers’ AstraZeneca Deal Is a Win Similar posts: Bristol-Myers Squibb Company (NYSE:BMY) | Bristol-Myers Squibb Foundation Marks World Diabetes Day with Four Grants Addressing Link Between Diabetes, Depression and Distress Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb Gains 6% on Promising Cancer Treatment, Upgrade Market Update on Bristol-Myers Squibb Company (NYSE:BMY) – June 2014 Options Now Available For Bristol-Myers Squibb (BMY)